102.67
Precedente Chiudi:
$102.76
Aprire:
$105
Volume 24 ore:
169.33K
Relative Volume:
3.30
Capitalizzazione di mercato:
$4.66B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-19.69%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Billiontoone Inc Stock (BLLN) Company Profile
Nome
Billiontoone Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BLLN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BLLN
Billiontoone Inc
|
102.67 | 4.67B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Iniziato | BTIG Research | Buy |
| 2025-12-01 | Iniziato | JP Morgan | Overweight |
| 2025-12-01 | Iniziato | Jefferies | Hold |
| 2025-12-01 | Iniziato | Piper Sandler | Overweight |
| 2025-12-01 | Iniziato | Stifel | Buy |
| 2025-12-01 | Iniziato | Wells Fargo | Equal Weight |
| 2025-12-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Billiontoone Inc Borsa (BLLN) Ultime notizie
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
BillionToOne (NASDAQ: BLLN) schedules Q3 2025 results and call for Dec. 9, 2025 - Stock Titan
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - whbl.com
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com South Africa
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Stifel Initiates BillionToOne at Buy With $145 Price Target - marketscreener.com
Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
JPMorgan Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
Wells Fargo Initiates BillionToOne at Equalweight With $110 Price Target - MarketScreener
William Blair Initiates BillionToOne at Outperform - MarketScreener
BTIG Initiates BillionToOne at Buy With $160 Price Target - marketscreener.com
BillionToOne’s Hot IPO Has Analysts Onboard Early - Finimize
BillionToOne: Disrupting Diagnostics with Groundbreaking Tech - Devdiscourse
William Blair initiates coverage on BillionToOne stock with Outperform rating By Investing.com - Investing.com South Africa
BillionToOne initiated with an Equal Weight at Wells Fargo - TipRanks
William Blair initiates coverage on BillionToOne stock with Outperform rating - Investing.com
BillionToOne: A High-Growth Leader in Prenatal Genetics and Oncology with Strong Buy Rating - TipRanks
BillionToOne initiated with a Hold at Jefferies - TipRanks
BillionToOne initiated with an Overweight at Piper Sandler - TipRanks
Jefferies initiates BillionToOne stock with Hold rating, $117 price target By Investing.com - Investing.com Australia
BillionToOne initiated with a Buy at Stifel - TipRanks
BillionToOne’s Innovative Platform Poised for Growth in Reproductive Health and Oncology Markets - TipRanks
BillionToOne’s Innovative Sequencing Platform and Strong Growth Prospects Justify Buy Rating and $150 Price Target - TipRanks
BillionToOne initiated with an Overweight at JPMorgan - TipRanks
Balanced Outlook on BillionToOne, Inc.: High Growth Potential Amidst Competitive Challenges - TipRanks
BillionToOne, Inc.: Strong Market Position and Profitability Justify Buy Rating - TipRanks
Piper Sandler initiates BillionToOne stock coverage with Overweight rating - Investing.com India
Jefferies initiates BillionToOne stock with Hold rating, $117 price target - Investing.com
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains - Investing.com India
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains By Investing.com - Investing.com South Africa
BLLNBilliontoone Inc Stock Price and Quote - Finviz
BillionToOne, Inc. (BLLN) stock major holders - Yahoo Finance Australia
BillionToOne, Inc. (BLLN) Stock Major Holders - Yahoo! Finance Canada
IPO Stock Taps Massive Medicare Market, Soars Into Buy Range - Investor's Business Daily
BillionToOne, Inc. (BLLN) Beta - Zacks Investment Research
BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025) - ts2.tech
BillionToOne, Inc. (BLLN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Billiontoone Inc Azioni (BLLN) Dati Finanziari
Non sono disponibili dati finanziari per Billiontoone Inc (BLLN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):